by Truveta staff | Oct 29, 2025 | News
Today, Truveta was featured as #1 on LinkedIn’s Top Startups in Seattle for 2025 list. The ranking highlights ten growing start-up companies in the Seattle area. Last year, Truveta was ranked #3 on the inaugural Seattle list. Earlier this month, Truveta was also...
by Truveta staff | Sep 23, 2025 | News
Medical device manufacturers and regulators face a persistent challenge: obtaining a complete, clinically rich view of how devices are used, how safe they are, and how they affect patient outcomes. Historically, researchers have been limited to claims, chargemaster,...
by Truveta staff | May 8, 2025 | News
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta is leading a new era in cancer research, delivering an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and...
by Terry Myerson, CEO | Mar 27, 2025 | News
At Truveta, our mission is Saving Lives with Data, and we are thinking about the HHS leadership mission of making American’s healthier, and how to help the talented scientists of HHS do more with less. We’d like to contribute to this important mission – starting...
by Michael Simonov, MD | Mar 26, 2025 | News
Today, we’re excited to celebrate our latest innovation in Truveta across both Truveta Data and Truveta Studio. Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. We...
by Terry Myerson, CEO | Jan 13, 2025 | News
Since Truveta’s inception 5 years ago, we have been tirelessly working to build a complete, clean, and timely dataset reflective of US health. Truveta Data now includes 120M de-identified patients’ medical records updated daily. It’s been incredible to work with the...
